Skip to main content

Published locations for Gefitinib missed noninferiority endpoint vs. erlotinib in lung cancer trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Gefitinib missed noninferiority endpoint vs. erlotinib in lung cancer trial

User login

  • Reset your password
  • /content/gefitinib-missed-noninferiority-endpoint-vs-erlotinib-lung-cancer-trial
  • /oncologypractice/article/107817/lung-cancer/gefitinib-missed-noninferiority-endpoint-vs-erlotinib
  • /hematology-oncology/article/107817/lung-cancer/gefitinib-missed-noninferiority-endpoint-vs-erlotinib